Clinical Trials
7 trialsNCT03282097 2025-08-11
DECAD
Indiana University
Phase NA Completed
NCT04971733 2025-06-10
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Phase 1/2 Completed
NCT01083316 2020-09-25
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Boston Medical Center
Phase 2 Completed
NCT02767609 2019-04-30
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
Loma Linda University
Phase NA Completed
NCT02632786 2019-04-05
PRONTO
Prothena Biosciences Ltd.
Phase 2 Completed
NCT00348140 2017-09-05
REFLECT-3
GlaxoSmithKline
Phase 3 Completed
NCT00428090 2017-05-19
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
GlaxoSmithKline
Phase 3 Completed